Abstract P3-05-16: The effect of HER-2/neu inhibition on prolonging clinical benefit with fulvestrant treatment for metastatic estrogen receptor positive breast cancer patients treated with trastuzumab

Her 2 ◽

P5-14-18: Today's Estrogen Receptor Positive/Her-2-neu Receptor Negative Breast Cancer Patients Do Significantly Better Than Yesterday's Estrogen Receptor Positive Breast Cancer Patients.

10.1158/0008-5472.sabcs11-p5-14-18 ◽

2011 ◽

Author(s):

EV Madsen ◽

SG Elias ◽

PD Gobardhan ◽

Oort PM van ◽

der Ent FW van ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her 2 ◽

Better Than ◽

Abstract P3-07-10: The association between the expression of progesterone receptor and clinical benefit of adjuvant trastuzumab in estrogen receptor-positive and HER2-positive breast cancer patients

10.1158/1538-7445.sabcs15-p3-07-10 ◽

2016 ◽

Author(s):

HW Lee ◽

SG Ahn ◽

JT Park ◽

BS Yang ◽

S Park ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Progesterone Receptor ◽

Cancer Patients ◽

Clinical Benefit ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration

Cancer Reports ◽

10.1002/cnr2.1431 ◽

2021 ◽

Author(s):

Sirus Djahansouzi ◽

Bettina Hanstein ◽

Daniel Rein ◽

Michel Clees ◽

Werner Rath

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tumor Progression ◽

Cancer Patients ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Receptor Conversion ◽

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting

Molecular Oncology ◽

10.1016/j.molonc.2014.07.003 ◽

2014 ◽

Vol 8 (8) ◽

pp. 1679-1689 ◽

Cited By ~ 11

Author(s):

Anieta M. Sieuwerts ◽

Maria B. Lyng ◽

Marion E. Meijer-van Gelder ◽

Vanja de Weerd ◽

Fred C.G.J. Sweep ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Gene Signatures ◽

P30. The use of HER2 receptors status as a prognostic index for estrogen receptor positive breast cancer patients

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-s2-p21 ◽

2014 ◽

Vol 2 (S2) ◽

Author(s):

A Tawfeek

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Prognostic Index ◽

Breast Cancer Patients ◽

FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients

Annals of Surgical Oncology ◽

10.1245/s10434-014-4313-2 ◽

2015 ◽

Vol 22 (6) ◽

pp. 2034-2039 ◽

Cited By ~ 15

Author(s):

Chenpu Xu ◽

Qun Wei ◽

Jufeng Guo ◽

Ji Chun Zhou ◽

Jin Mei ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Response To Chemotherapy ◽

Foxa1 Expression ◽

Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature

BMC Cancer ◽

10.1186/1471-2407-8-339 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 37

Author(s):

Andrew Tutt ◽

Alice Wang ◽

Charles Rowland ◽

Cheryl Gillett ◽

Kit Lau ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Distant Metastasis ◽

Risk Estimation ◽

Breast Cancer Patients ◽

Rt Pcr ◽

Node Negative ◽

Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial

Journal of Nuclear Medicine ◽

10.2967/jnumed.117.194654 ◽

2017 ◽

Vol 59 (2) ◽

pp. 197-203 ◽

Cited By ~ 12

Author(s):

Michel Paquette ◽

Éric Lavallée ◽

Serge Phoenix ◽

René Ouellet ◽

Helena Senta ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Estrogen Receptor ◽

Cancer Patients ◽

Phase Ii ◽

The Novel ◽

Breast Cancer Patients ◽

Ongoing Phase ◽

Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05505-4 ◽

2019 ◽

Vol 179 (3) ◽

pp. 687-697

Author(s):

Min Hwan Kim ◽

Gun Min Kim ◽

Jee Hung Kim ◽

Jee Ye Kim ◽

Hyung Seok Park ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Poor Prognosis ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

BMC Cancer ◽

10.1186/s12885-018-4558-4 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 3

Author(s):

Elisabetta Venturelli ◽

Annalisa Orenti ◽

Aline S. C. Fabricio ◽

Giulia Garrone ◽

Roberto Agresti ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Observational Study ◽

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients ◽

Postmenopausal Estrogen ◽